サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386285

インフルエンザワクチン市場レポート：2030年までの動向、予測、競合分析

Influenza Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

インフルエンザワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

インフルエンザワクチンの動向と予測

世界のインフルエンザワクチン市場は、2024年から2030年までのCAGRが6.8%で、2030年までに推定112億2,000万米ドルに達すると予測されます。この市場の主な促進要因は、より効果的で侵襲性の低いインフルエンザワクチンに対する需要の高まり、インフルエンザワクチンの利点に対する意識の高まり、インフルエンザワクチン接種を促進するための政府の支援策などです。世界のインフルエンザワクチン市場の将来は、病院・小売薬局と政府供給チャネルにおける機会によって有望視されています。

インフルエンザワクチン市場の洞察

Lucintelの予測では、不活化ワクチンはその安全性と有効性から需要が高まっており、予測期間中に高い成長が見込まれます。

この市場の中では、病院と小売薬局がインフルエンザワクチンの入手が最も簡単でアクセスしやすい場所であるため、予測期間中に最も高い成長が見込まれます。

北米は、インフルエンザの罹患率が高いこと、ヘルスケアシステムが確立していること、ワクチン接種に対する嗜好性が高いことから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のインフルエンザワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のインフルエンザワクチン市場動向（2018～2023年）と予測（2024～2030年）
  • ワクチンタイプ別の世界のインフルエンザワクチン市場
    • 不活性化
    • 弱毒化
  • 流通チャネル別の世界のインフルエンザワクチン市場
    • 病院および小売薬局
    • 政府のサプライヤー
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のインフルエンザワクチン市場
  • 北米のインフルエンザワクチン市場
  • 欧州のインフルエンザワクチン市場
  • アジア太平洋インフルエンザワクチン市場
  • その他地域インフルエンザワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • ワクチンタイプ別の世界のインフルエンザワクチン市場の成長機会
    • 流通チャネル別の世界のインフルエンザワクチン市場の成長機会
    • 地域別の世界のインフルエンザワクチン市場の成長機会
  • 世界のインフルエンザワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のインフルエンザワクチン市場の生産能力拡大
    • 世界のインフルエンザワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GSK
  • AstraZeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT
目次

Influenza Vaccine Trends and Forecast

The future of the global influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels. The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.

A more than 150-page report is developed to help in your business decisions.

Influenza Vaccine by Segment

The study includes a forecast for the global influenza vaccine by vaccine type, distribution channel, and region.

Influenza Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated
  • Live Attenuated

Influenza Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

Influenza Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Influenza Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza vaccine companies profiled in this report include-

  • GSK
  • Astrazeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT

Influenza Vaccine Market Insights

Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.

Within this market, hospital & retail pharmacy is expected to witness highest growth over the forecast period as they are the easiest and most accessible locations to acquire a flu vaccine.

North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.

Features of the Global Influenza Vaccine Market

Market Size Estimates: Influenza vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Influenza vaccine market size by vaccine type, distribution channel, and region in terms of value ($B).

Regional Analysis: Influenza vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, distribution channels, and regions for the influenza vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the influenza vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the influenza vaccine market size?

Answer: The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030.

Q.2 What is the growth forecast for influenza vaccine market?

Answer: The global influenza vaccine market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the influenza vaccine market?

Answer: The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.

Q4. What are the major segments for influenza vaccine market?

Answer: The future of the influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels.

Q5. Who are the key influenza vaccine market companies?

Answer: Some of the key influenza vaccine companies are as follows:

  • GSK
  • Astrazeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT

Q6. Which influenza vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.

Q7. In influenza vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the influenza vaccine market by vaccine type (inactivated and live attenuated), distribution channel (hospital & retail pharmacies, government suppliers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Influenza Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Influenza Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Influenza Vaccine Market by Vaccine Type
    • 3.3.1: Inactivated
    • 3.3.2: Live Attenuated
  • 3.4: Global Influenza Vaccine Market by Distribution Channel
    • 3.4.1: Hospital & Retail Pharmacies
    • 3.4.2: Government Suppliers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Influenza Vaccine Market by Region
  • 4.2: North American Influenza Vaccine Market
    • 4.2.2: North American Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.3: European Influenza Vaccine Market
    • 4.3.1: European Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.3.2: European Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.4: APAC Influenza Vaccine Market
    • 4.4.1: APAC Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.4.2: APAC Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.5: ROW Influenza Vaccine Market
    • 4.5.1: ROW Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.5.2: ROW Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Influenza Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Influenza Vaccine Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Influenza Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Influenza Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Influenza Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Influenza Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GSK
  • 7.2: AstraZeneca
  • 7.3: SINOVAC
  • 7.4: Pfizer
  • 7.5: Vaxess Technologies
  • 7.6: CSL
  • 7.7: EMERGENT